Human papillomavirus-related anogenital premalignancies and cancer in renal transplant recipients: A Danish nationwide, registry-based cohort study.
Adult
Anus Neoplasms
/ etiology
Cohort Studies
Denmark
/ epidemiology
Female
Follow-Up Studies
Humans
Kidney Transplantation
/ adverse effects
Male
Middle Aged
Papillomaviridae
/ isolation & purification
Papillomavirus Infections
/ complications
Precancerous Conditions
/ etiology
Prognosis
Registries
Transplant Recipients
/ statistics & numerical data
Urogenital Neoplasms
/ etiology
anogenital
cancer
cohort
dysplasia
human papillomavirus
intraepithelial neoplasia
premalignancies
registry-based
renal transplant recipients
Journal
International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124
Informations de publication
Date de publication:
01 05 2020
01 05 2020
Historique:
received:
02
04
2019
revised:
21
06
2019
accepted:
02
07
2019
pubmed:
11
7
2019
medline:
1
7
2020
entrez:
11
7
2019
Statut:
ppublish
Résumé
In this registry-based cohort study, we estimated the risk of human papillomavirus (HPV)-related anogenital premalignancies and cancer in renal transplant recipients (RTRs) compared to a nontransplanted comparison cohort. We identified all first-time RTRs in Denmark during 1990-2015 in a nationwide nephrology register. For each RTR, we randomly selected 50 age- and sex-matched non-RTRs from the background population. The study population was followed for diagnoses of cervical, vaginal, vulvar, penile and anal intraepithelial neoplasia grades 2-3 (IN2/3) and cancer for up to 27 years. We estimated hazard ratios (HRs) of anogenital IN2/3 and cancer in RTRs vs. non-RTRs by Cox regression separately for men and women using age as underlying timescale, adjusting for income, education, HPV vaccination and immunocompromising conditions. We included 4,261 RTRs and 213,673 non-RTRs. RTRs had increased hazard of cervical (HR = 2.1, 95% CI: 1.7-2.8), vaginal (HR = 35.0, 95% CI: 13.9-87.7), vulvar (HR = 16.4, 95% CI: 10.4-25.8), penile (HR = 21.9, 95% CI: 11.1-43.5) and anal (women: HR = 51.1, 95% CI: 28.0-93.1; men: HR = 39.0, 95% CI: 16.7-91.1) IN2/3. The HRs of anogenital cancers were also increased at most sites. The HR of anogenital IN2/3 in female RTRs tended to be higher during graft function than during dialysis. In female RTRs aged <40 years at transplantation, 10-15% had cervical IN2/3 and 5-12% had vaginal/vulvar/anal IN2/3 within 20 years after transplantation, compared to 4-8 and 0.2-0.4%, respectively, of female non-RTRs. In conclusion, RTRs had substantially higher risk of HPV-related anogenital premalignancies and cancer than non-RTRs.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2413-2422Informations de copyright
© 2019 UICC.
Références
Global Observatory on Donation and Transplantation. Newsletter Transplant. International figures on donation and transplantation 2017, vol. 23. Strasbourg: European Directorate for the Quality of Medicines and Health Care Council of Europe, 2018.
Vajdic CM, van Leeuwen MT. Cancer incidence and risk factors after solid organ transplantation. Int J Cancer 2009;125:1747-54.
Schiffman M, Doorbar J, Wentzensen N, et al. Carcinogenic human papillomavirus infection. Nat Rev Dis Primers 2016;2:16086.
Lin C, Franceschi S, Clifford GM. Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis. Lancet Infect Dis 2018;18:198-206.
Bertoli HK, Rasmussen CL, Sand FL, et al. Human papillomavirus and p16 in squamous cell carcinoma and intraepithelial neoplasia of the vagina. Int J Cancer 2018;145:78-86.
Faber MT, Sand FL, Albieri V, et al. Prevalence and type distribution of human papillomavirus in squamous cell carcinoma and intraepithelial neoplasia of the vulva. Int J Cancer 2017;141:1161-9.
Olesen TB, Sand FL, Rasmussen CL, et al. Prevalence of human papillomavirus DNA and p16INK4a in penile cancer and penile intraepithelial neoplasia: a systematic review and meta-analysis. Lancet Oncol 2019;20:145-58.
Skov Dalgaard L, Fassel U, Østergaard LJ, et al. Risk of human papillomavirus-related cancers among kidney transplant recipients and patients receiving chronic dialysis-an observational cohort study. BMC Nephrol 2013;14:137.
Krynitz B, Edgren G, Lindelöf B, et al. Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008-a Swedish population-based study. Int J Cancer 2013;132:1429-38.
Hibberd AD, Trevillian PR, Wlodarczyk JH, et al. Effect of immunosuppression for primary renal disease on the risk of cancer in subsequent renal transplantation: a population-based retrospective cohort study. Transplantation 2013;95:122-7.
Collett D, Mumford L, Banner NR, et al. Comparison of the incidence of malignancy in recipients of different types of organ: a UKregistry audit. Am J Transplant 2010;10:1889-96.
van Leeuwen MT, Webster AC, McCredie MR, et al. Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study. BMJ 2010;340:c570.
Villeneuve PJ, Schaubel DE, Fenton SS, et al. Cancer incidence among Canadian kidney transplant recipients. Am J Transplant 2007;7:941-8.
Vajdic CM, McDonald SP, McCredie MR, et al. Cancer incidence before and after kidney transplantation. JAMA 2006;296:2823-31.
Kasiske BL, Snyder JJ, Gilbertson DT, et al. Cancer after kidney transplantation in the United States. Am J Transplant 2004;4:905-13.
Birkeland SA, Lokkegaard H, Storm HH. Cancer risk in patients on dialysis and after renal transplantation. Lancet 2000;355:1886-7.
Birkeland SA, Storm HH, Lamm LU, et al. Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int J Cancer 1995;60:183-9.
Fairley CK, Sheil AG, McNeil JJ, et al. The risk of ano-genital malignancies in dialysis and transplant patients. Clin Nephrol 1994;41:101-5.
Hinten F, Hilbrands LB, Meeuwis KA, et al. Reactivation of latent HPV infections after renal transplantation. Am J Transplant 2017;17:1563-73.
Meeuwis KA, Hilbrands LB, IntHout J, et al. Cervicovaginal HPV infection in female renal transplant recipients: an observational, self-sampling based, cohort study. Am J Transplant 2015;15:723-33.
Aggarwal R, Suri V, Awasthi S, et al. Prevalence and genotypes of HPV in female renal transplant recipients in North India. Int J Gynecol Pathol 2014;33:537-42.
Mazanowska N, Pietrzak B, Kaminski P, et al. Prevalence of cervical high-risk human papillomavirus infections in kidney graft recipients. Ann Transplant 2013;18:656-60.
Origoni M, Stefani C, Dell'Antonio G, et al. Cervical human papillomavirus in transplanted Italian women: a long-term prospective follow-up study. J Clin Virol 2011;51:250-4.
Seshadri L, George SS, Vasudevan B, et al. Cervical intraepithelial neoplasia and human papilloma virus infection in renal transplant recipients. Indian J Cancer 2001;38:92-5.
Ghazizadeh S, Lessan-Pezeshki M, Einollahi B, et al. Uterine cervical intraepithelial neoplasia in renal transplantation. Transplant Proc 2001;33:2817.
Ogunbiyi OA, Scholefield JH, Raftery AT, et al. Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients. Br J Surg 1994;81:365-7.
Fairley CK, Chen S, Tabrizi SN, et al. Prevalence of HPV DNA in cervical specimens in women with renal transplants: a comparison with dialysis-dependent patients and patients with renal impairment. Nephrol Dial Transplant 1994;9:416-20.
Alloub MI, Barr BB, McLaren KM, et al. Human papillomavirus infection and cervical intraepithelial neoplasia in women with renal allografts. BMJ 1989;298:153-6.
Halpert R, Fruchter RG, Sedlis A, et al. Human papillomavirus and lower genital neoplasia in renal transplant patients. Obstet Gynecol 1986;68:251-8.
Heaf J. The Danish nephrology registry. Clin Epidemiol 2016;8:621-7.
Pedersen CB. The Danish civil registration system. Scand J Public Health 2011;39(7 Suppl):22-5.
Bjerregaard B, Larsen OB. The Danish pathology register. Scand J Public Health 2011;39(7 Suppl):72-4.
Gjerstorff ML. The Danish cancer registry. Scand J Public Health 2011;39(7 Suppl):42-5.
Danish National Board of Health. The modernised cancer registry - methods and quality [in Danish]. Copenhagen: Danish National Board of Health, 2009.
Statistics Denmark. Overview of registers and variables [in Danish]. Available from: http://www.dst.dk/da/TilSalg/Forskningsservice/Data/Register_Variabeloversigter [cited 13 November 2018].
Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health 2011;39(7 Suppl):30-3.
VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med 2017;167:268-74.
Meeuwis KA, van Rossum MM, van de Kerkhof PC, et al. Skin cancer and (pre)malignancies of the female genital tract in renal transplant recipients. Transpl Int 2010;23:191-9.
Engels EA, Pfeiffer RM, Fraumeni JF Jr, et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011;306:1891-901.
Guba M, Graeb C, Jauch KW, et al. Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation. Transplantation 2004;77:1777-82.
Larsen HK, Thomsen LT, Haedersdal M, et al. Risk of genital warts in renal transplant recipients-a registry-based, prospective cohort study. Am J Transplant 2018;19:156-65.
Pham PT, Everly M, Faravardeh A, et al. Management of patients with a failed kidney transplant: dialysis reinitiation, immunosuppresion weaning, and transplantectomy. World J Nephrol 2015;4:148-59.
Madeleine MM, Finch JL, Lynch CF, et al. HPV-related cancers after solid organ transplantation in the United States. Am J Transplant 2013;13:3202-9.
Petry KU, Horn J, Luyten A, et al. Punch biopsies shorten time to clearance of high-risk human papillomavirus infections of the uterine cervix. BMC Cancer 2018;18:318.
Stoler MM, Vichnin MD, Ferenczy A, et al. The accuracy of colposcopic biopsy: analyses from the placebo arm of the Gardasil clinical trials. Int J Cancer 2011;128:1354-62.
Hommel K, Rasmussen S, Madsen M, et al. The Danish registry on regular dialysis and transplantation: completeness and validity of incident patient registration. Nephrol Dial Transplant 2010;25:947-51.
Engberg H, Wehberg S, Bistrup C, et al. Cancer risk and mortality after kidney transplantation: a population-based study on differences between Danish centres using standard immunosuppression with and without glucocorticoids. Nephrol Dial Transplant 2016;31:2149-56.
Danish National Board of Health. Screening against cervical cancer - recommendations [in Danish]. Copenhagen: Danish National Board of Health, 2012 Available from: https://www.sst.dk/~/media/B1211EAFEDFB47C5822E883205F99B79.ashx [cited 21 February 2019].
Ebisch RMF, Rutten DWE, IntHout J, et al. Long-lasting increased risk of human papillomavirus-related carcinomas and premalignancies after cervical intraepithelial neoplasia grade 3: a population-based cohort study. J Clin Oncol 2017;35:2542-50.
Acuna SA, Huang JW, Scott AL, et al. Cancer screening recommendations for solid organ transplant recipients: a systematic review of clinical practice guidelines. Am J Transplant 2017;17:103-14.
Leeds IL, Fang SH. Anal cancer and intraepithelial neoplasia screening: a review. World J Gastrointest Surg 2016;8:41-51.
Rogers LJ, Cuello MA. Cancer of the vulva. Int J Gynaecol Obstet 2018;143(Suppl 2):4-13.
Martínez-Gómez X, Curran A, Campins M, et al. Multidisciplinary, evidence-based consensus guidelines for human papillomavirus (HPV) vaccination in high-risk populations, Spain, 2016. Euro Surveill 2019;24. https://doi.org/10.2807/1560-7917
Kumar D, Unger ER, Panicker G, et al. Immunogenicity of quadrivalent human papillomavirus vaccine in organ transplant recipients. Am J Transplant 2013;13:2411-7.